Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a).

Autoantibodies to oxidised LDL Bariatric surgery Obesity Oxidised phospholipids Weight reduction apoB-100 immune complexes lipoprotein(a)

Journal

Journal of clinical lipidology
ISSN: 1933-2874
Titre abrégé: J Clin Lipidol
Pays: United States
ID NLM: 101300157

Informations de publication

Date de publication:
Historique:
received: 06 08 2020
revised: 04 12 2020
accepted: 06 12 2020
pubmed: 2 2 2021
medline: 17 12 2021
entrez: 1 2 2021
Statut: ppublish

Résumé

Obesity is associated with adverse cardiovascular outcomes and this is improved following bariatric surgery. Oxidised phospholipids (OxPL) are thought to reflect the pro-inflammatory effects of lipoprotein(a) [Lp(a)], and both are independent predictors of cardiovascular disease. Our study sought to determine the impact of bariatric surgery on OxPL, biomarkers of oxidised LDL (OxLDL) and Lp(a). This is a prospective, observational study of 59 patients with severe obesity undergoing bariatric surgery. Blood samples were obtained prior to surgery and at 6 and 12 months after. Sixteen patients attending the tertiary medical weight management clinic at the same centre were also recruited for comparison. Lipid and metabolic blood parameters, OxLDL, OxPL on apolipoprotein B-100 (OxPL-apoB), IgG and IgM autoantibodies to MDA-LDL, IgG and IgM apoB-immune complexes and Lp(a) were measured. Reduction in body mass index (BMI) was significant following bariatric surgery, from median 48 kg/m Bariatric surgery results in a significant increase in Lp(a) but reductions in OxPL-apoB and other biomarkers of oxidised lipoproteins, suggesting increased synthetic capacity and reduced oxidative stress. These biomarkers might be clinically useful to monitor physiological effects of weight loss interventions.

Sections du résumé

BACKGROUND
Obesity is associated with adverse cardiovascular outcomes and this is improved following bariatric surgery. Oxidised phospholipids (OxPL) are thought to reflect the pro-inflammatory effects of lipoprotein(a) [Lp(a)], and both are independent predictors of cardiovascular disease.
OBJECTIVE
Our study sought to determine the impact of bariatric surgery on OxPL, biomarkers of oxidised LDL (OxLDL) and Lp(a).
METHODS
This is a prospective, observational study of 59 patients with severe obesity undergoing bariatric surgery. Blood samples were obtained prior to surgery and at 6 and 12 months after. Sixteen patients attending the tertiary medical weight management clinic at the same centre were also recruited for comparison. Lipid and metabolic blood parameters, OxLDL, OxPL on apolipoprotein B-100 (OxPL-apoB), IgG and IgM autoantibodies to MDA-LDL, IgG and IgM apoB-immune complexes and Lp(a) were measured.
RESULTS
Reduction in body mass index (BMI) was significant following bariatric surgery, from median 48 kg/m
CONCLUSIONS
Bariatric surgery results in a significant increase in Lp(a) but reductions in OxPL-apoB and other biomarkers of oxidised lipoproteins, suggesting increased synthetic capacity and reduced oxidative stress. These biomarkers might be clinically useful to monitor physiological effects of weight loss interventions.

Identifiants

pubmed: 33518459
pii: S1933-2874(20)30339-1
doi: 10.1016/j.jacl.2020.12.002
pii:
doi:

Substances chimiques

Lipoproteins, LDL 0
Phospholipids 0
oxidized low density lipoprotein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-331

Informations de copyright

Copyright © 2020 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Auteurs

Jan Hoong Ho (JH)

Department of Medicine, Manchester University NHS Foundation Trust, Manchester, UK; Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK.

Safwaan Adam (S)

Department of Medicine, Manchester University NHS Foundation Trust, Manchester, UK; Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK.

Yifen Liu (Y)

Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK.

Shazli Azmi (S)

Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK.

Shaishav Dhage (S)

Department of Medicine, Manchester University NHS Foundation Trust, Manchester, UK; Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK.

Akheel A Syed (AA)

Department of Diabetes & Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK.

Basil J Ammori (BJ)

Department of Surgery, Salford Royal NHS Foundation Trust, Salford, UK.

Rachelle Donn (R)

Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK.

Adrian Heald (A)

Department of Diabetes & Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK.

Martin J Gibson (MJ)

Department of Diabetes & Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK.

Rayaz A Malik (RA)

Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK; Weill Cornell Medicine-Qatar, Doha, Qatar.

Xiaohong Yang (X)

Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, USA.

Paul N Durrington (PN)

Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK.

Sotirios Tsimikas (S)

Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, USA. Electronic address: stsimikas@health.ucsd.edu.

Handrean Soran (H)

Department of Medicine, Manchester University NHS Foundation Trust, Manchester, UK; Lipid Research Group, Division of Medical Sciences, The University of Manchester, Manchester, UK. Electronic address: hsoran@aol.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH